シャドーイング練習: A pediatric cerebrovascular approach: techniques and challenges - YouTubeで英語スピーキングを学ぶ
C2
Music My
138 文
文が短すぎたり長すぎる場合は、Editをタップして調整してください。
1
Music My
2
practice is unique in the fact that I do about 90 percent,
3
85 percent of what I do is all children.
4
children with vascular malformations, both of the brain and the neck, maxillofacial areas.
5
We receive them from newborn actually to 19, 18 years of age.
6
We do of course also adults with vascular malformations,
7
but as things are evolving and you can see how fantastic this course is and the tremendous progress that has exist.
8
So children are not small adults and that has happened throughout medicine.
9
There was the general doctor first,
10
then became pediatricians, which was obviously that required different things.
11
So within the vascular lesions of the human body,
12
there's a certain amount of diseases that occur in children primarily,
13
and that affect children sometimes exclusively.
14
So, based on my practice,
15
I have dedicated myself to improve the treatment in those children,
16
decrease the radiation, decrease the time of the procedure,
17
being very meticulous with the technique, very meticulous with fluids.
18
For small children that are in severe heart problems with brain problems,
19
if you use the same techniques in adults,
20
you actually could have a lot of harm.
21
So there are dedicated, specific problems that occur in children.
22
There are specific, dedicated challenges,
23
technical, medical, physiological, that are specific for children.
24
And there's even difference between children and newborns.
25
We have newborns that are born in severe heart failure with a disease called vein of gallant malformation
26
that even treated is lethal within the first year of life.
27
So those children require techniques,
28
for example, we develop techniques to go through the umbilical artery.
29
So we can actually place a cathode from the umbilical artery to enter the body,
30
to then navigate into the brain.
31
In this pediatric population, the diseases are rare,
32
so it's very hard to do really trials.
33
We're more involved in developing devices,
34
actually because coming from children,
35
they can be translated towards adults.
36
We also have a lot of patients,
37
or practices, patients of rare diseases,
38
such as vascular malformation of the maxillofacial area.
39
very difficult to treat.
40
So we have developed techniques like direct percutaneous puncture.
41
Instead of going from the femoral artery and trying to catheterize them,
42
it's to actually use 3D angiography or the eye guide
43
or the different types of technologies that have been developed for adults
44
and try to use them to place catheters or needles directly into the malformation.
45
And that has changed the whole ballgame.
46
We also involve trying to develop things which are called sclerotherapy.
47
Sclerotherapy is a technique in which you inject something that will damage the endothelium.
48
And then the healing of that scarring,
49
that will produce scarring, will actually sclerose or thrombose or close and scar those vascular malformations that they cannot feel.
50
And that includes venous malformation.
51
That includes lymphatic malformations.
52
That includes arteriovenous malformation.
53
And we're using biological substances such as chemotherapeutic agents, bleomycin for example.
54
And they've made a tremendous change in the outcome of this patient.
55
Actually, we're trying to use more and more ultrasound to guide ourselves to do these procedures.
56
Also, within the medical industry of x-rays,
57
we're forcing the manufacturers to create things like last image hold.
58
And then with that last image hold,
59
will, for example, collimate, try to center memories so that we don't have to radiate these children.
60
Mothers come to me and ask me that,
61
will my child have a stroke while you're doing this horrible malformation?
62
They ask me how much radiation are they gonna get?
63
Or the anesthesia?
64
Well, there is a potential role for endovascular radiosurgery.
65
I worked like 15, 20 years ago to try to treat vascular malformations that way.
66
But radiation is a difficult thing to control.
67
It's a difficult thing to prove,
68
a difficult thing to get approved through a regulatory pathway like the Food and Drug Administration and so on.
69
And dangerous for everyone, including you as an operator.
70
Everything is dangerous if it's improperly used.
71
You know, if you have a genie and you let the genie out of the box and there's no control,
72
it can be very, very dangerous.
73
So I would say that radiation has a potential,
74
but it is not something that is around the corner.
75
The tools that we have today are pretty much adaptation of adults to children.
76
So we're still at the beginning.
77
We're very much interested in developing tools that are designed for newborns and for children,
78
which today do not exist.
79
So we take a catheter that is a meter and a half,
80
because it's the only catheter that we have.
81
The technology exists, but the market is so small
82
that industry is not very interested in developing high technology for a very small market.
83
And this is not simply the question of smaller arteries.
84
It's a whole question of a different anatomy that you're dealing with.
85
It's a different anatomy.
86
It's a different technology necessary for the stiffness, for example.
87
You know, the blood vessels in children are more fragile in a sense.
88
But on the other hand, they're more elastic.
89
So they have their own specific problems,
90
both technically as well as physiological.
91
One of the biggest questions that we have is if we take a device,
92
for example a stent, that is developed for adults which have stopped growing and we put them in small children,
93
what would happen to those vessels as we increase in size?
94
And therefore, personally, we have a lot of skepticism of using stents unless we are really forced.
95
And the other side of the coin is we're going to press
96
and push industry to develop bioactive or biodegradable devices so that
97
if I put a stent in a little child and that stent will then be reabsorbed,
98
it will permit then the normal physiologic growth.
99
Biodegradable, bioabsorbable, biocompatible.
100
It's one of the great, great, great potential expansion.
101
If we can develop it for children,
102
it can then be transferred to adults.
103
What is interesting is that we've done very small devices based on trying to do it for pediatrics,
104
and those have translated to go to the adult,
105
which permits you to go to more distal circulation.
106
I think that's very valuable for the training of physicians.
107
You know, when I started,
108
it was see one, do one,
109
teach one, that no longer applies.
110
We're not, it's just so much better to train,
111
and I'm very involved in the training of physicians,
112
training physicians in a in vitro model.
113
You know, get all, I mean,
114
you actually today, the reproduction is, Dr. Moret, so fantastic.
115
You know, it's literally like the real thing.
116
But then you get the physician to learn.
117
You get the physician to train,
118
you get the physician to try,
119
you get the physician to make the mistake in a model.
120
By the time you transfer that to the real patient,
121
you have a much better trained physician.
122
And I think industry is now more and more turning to these models.
123
And the regulatory agencies are saying,
124
wait a second, you not only have to go and train in a model first.
125
You know, it used to be sometimes an animal.
126
Then, you know, as you know,
127
there's a lot of movement against training in animals.
128
So these things have replaced a lot of the training.
129
The regulatory agencies will force us to train physicians in this type of models that are now readily available.
130
3D printing can make exactly the same aneurysm immediately, right away.
131
And not only that, I can make 20 of those,
132
or 50, or 100 to train physicians.
133
So that I do believe that following that comes the proctoring.
134
In other words, now you're going to go,
135
this individual who's trained in the model is going to go do humans.
136
So when you go humans,
137
you go with somebody experience,
138
the fracture you, I think that is absolutely the way to go.
アプリをダウンロード
話したすべての文をAIが採点
TRENDING
人気動画
文脈と背景
このビデオでは、小児の脳血管アプローチについての専門的な技術と課題が紹介されています。講演者は、子供とその血管形成異常に特化した医療実践を行っており、新生児から18歳までの患者に対して75%から90%の診療を行っています。大人の患者も診るものの、子供に特有の問題に特化した治療法を開発し、処置の時間や放射線量を減少させる取り組みをしています。子供は小さな大人ではないと強調し、特定の技術的、医学的、そして生理的な挑戦があることを説明しています。
日常的なコミュニケーションのためのトップ5フレーズ
- 「子供の特異な病気について話すことが重要です。」 - 専門的な会話に役立つ。
- 「私たちは新生児からの治療に特化しています。」 - 自身の専門性を伝える際に使用できる。
- 「技術の進化が支援しています。」 - 最近の進展について説明するのに便利。
- 「具体的な技術を開発しています。」 - 開発中の技術について話す時に使える。
- 「血管形成異常に対する治療が必要です。」 - 専門分野に特化した議論のきっかけとして有効。
ステップバイステップシャドーイングガイド
このビデオを通してスピーキングスキルを向上させるためには、以下の手順を考慮してください。
- まずは聞く: ビデオの内容を集中して聞き込み、全体の流れを理解します。
- 重要なフレーズをリストアップする: 上記のフレーズをメモし、何度も繰り返し読むことで強化します。
- シャドーイングを行う: 聞いた音声に合わせて声に出して話すことで、発音やイントネーションを模倣します。
- 録音して確認する: 自分の声を録音し、実際の話し方と比較して改善点を見つけます。
- 反復練習: 定期的にこのプロセスを繰り返し、話す自信を高めましょう。 シャドーイングは、英語シャドーイングやIELTS スピーキング対策として非常に効果的な方法です。
この方法で練習することで、効果的に発話スキルが向上し、より自然な会話ができるようになります。ぜひ、shadowspeaksやその他のshadowing siteを活用して、新しい技術を実践してみてください。
シャドーイングとは？英語上達に効果的な理由
シャドーイング（Shadowing）は、もともとプロの通訳者養成プログラムで開発された言語学習法で、多言語習得者として知られるDr. Alexander Arguelles によって広く普及されました。方法はシンプルですが非常に効果的：ネイティブスピーカーの英語を聞きながら、1〜2秒の遅延で声に出してすぐに繰り返す——まるで「影（shadow）」のように話者を追いかけます。文法ドリルや受動的なリスニングと異なり、シャドーイングは脳と口の筋肉が同時にリアルタイムで英語を処理・再現することを強制します。研究により、発音精度、抑揚、リズム、連音、リスニング力、そして会話の流暢さが大幅に向上することが確認されています。IELTSスピーキング対策や自然な英語コミュニケーションを目指す方に特におすすめです。